A variety of estrogenic compounds exist in the environment, both natur
al (phyto- and fungal estrogens) and synthetic (e,g. pesticides, indus
trial contaminants), Recent studies have suggested that a number of re
productive abnormalities in wildlife and human populations could be du
e to embryonic exposure to ecoestrogens. These abnormalities include m
odifications in gonadal structure and functioning, abnormalities in ge
nital morphology and size, depressed plasma sex steroid concentrations
and various reproductive organ cancers, We review briefly some of the
se studies as well as those providing data that identify various ecoes
trogens. The data to date suggest that a wide variety of compounds can
interact with the estrogen receptor and can stimulate estrogen-associ
ated responses. Compared with 17 beta-estradiol, ecoestrogens have a w
eak binding affinity for the estrogen receptor and thus have been desc
ribed as weak estrogens, However, we hypothesize that the estrogenic a
ction of these compounds is augmented by their bioavailability and per
sistence, Initial testing demonstrates that some ecoestrogens show rel
atively little affinity for plasma binding proteins; thus, the majorit
y of the estrogenic compound in the plasma is available for translocat
ion into the cell, Likewise, many synthetic ecoestrogens appear to per
sist for months or years, stored in body fat. Future research needs to
examine in more detail the relative roles of receptor affinity, cellu
lar availability, and nuclear persistence in determining the estrogeni
city of ecoestrogens. Only then, will we begin to understand the true
role of these compounds in ecosystems.